Background: Milk and sugar are excessively consumed in a Western diet. There is increasing epidemiological evidence that the intake of unfermented pasteurized cow´s milk is associated with an increased risk of type 2 diabetes mellitus (T2D). It is the intention of this review to provide translational biochemical evidence for milk´s diabetogenic mode of action. Milk proteins provide the highest amounts of branched-chain amino acids (BCAAs) and thus contribute to total BCAA intake, which enhances BCAA plasma levels associated with increased risk of T2D. The consumption of pasteurized milk raises plasma levels of miRNA-29b, which is a diabetogenic miRNA promoting insulin resistance (IR). miRNA29b inhibits the activity of branched-chain αketa acid dehydrogenase, the rate limiting enzyme of BCAA catabolism, which is impaired in patients with IR and T2D. Milk consumption stimulates mTORC1 activity and increases insulin synthesis. β-cell mTORC1 is overactivated in T2D patients resulting in impaired autophagy which enhances endoplasmic reticulum (ER) stress associated with a greater risk of early β-cell apoptosis, the pathogenic hallmark of T2D. Chronic insulinotropic action of milk-derived BCAAs, IRpromoting mTORC1 overactivity, and miRNA-29b signaling combined with excessive glucosemediated insulin secretion overburden β-cell insulin homeostasis. Epidemiological and translational evidence identifies continued milk intake as a promoter of T2D, the most common metabolic disease of Western civilization.
INTRODUCTION
Type 2 diabetes mellitus (T2D), a worldwide epidemic, is a progressive metabolic disease initially developing insulin resistance (IR) with enhanced pancreatic β-islet activity, hyperinsulinemia, enhanced endoplasmic reticulum (ER) stress, and subsequent β-cell apoptosis with failure of insulin secretion. As the disease progresses, pancreatic β-cells are overstressed and fail to compensate for the IR. T2D is closely related to Western diets providing excessive amounts of sugar and saturated fats. Glucotoxicity and lipotoxicity are thus believed to play a key role in the pathogenesis of T2D. However, milk is another abundant component of a Western diet, which is the focus of this review. In 2017, a per capita milk consumption in the United States of 65.2 L (16.5 US gal) has been reported [1] , which underlines the presence of cow milk as a substantial factor of the dietary exposome. Milk exerts high insulinotropic effects [2] . A large and similar dissociation of the glycemic index and insulinemic index exists for both whole milk (42 + 5 and 148 + 14) and skim milk (37 + 9 and 140 + 13), respectively [3] . These observations clearly indicate that milk consumption has a stimulatory effect on insulin secretion and affects glucose homeostasis. Evidence provided by prospective cohort studies, which are frequently supported by the dairy industry, and limited randomized controlled trials (RCTs) suggests that total dairy consumption has a neutral or moderately beneficial effect on type 2 diabetes (T2D) risk [4] . In contrast, accumulating epidemiological evidence supports a relationship between the intake of non-fermented whole and skim milk and T2D [5] [6] [7] [8] [9] . It is the intention of this review to present epidemiologic and translational evidence underlining a key role of persistent cow milk consumption in the pathogenesis of T2D.
Epidemiological evidence
In 2005, Hoppe and et al. [5] observed that the intake of skim milk (53 g milk protein) but not lowfat meat (53 g protein) induced IR in 8-yr old Danish boys. A Mendelian randomization study in 97, 811 Danish individuals showed that especially the intake of fat-free milk is associated with a higher risk for T2D [6] . The Physicians´ Health study of U.S. male physicians (n = 21,660) reported a significant increase of diabetes risk from 1.7% to 2.6% by increasing the servings of whole milk from < 1/week to > 2/week and from 1.6% to 2.3% by increasing the servings of skim/low-fat milk from < 1/week to > 2/week, respectively [7] . A nested case-cohort within 8 European countries of the European Prospective Investigation into Cancer and Nutrition (EPIC) Study (n = 340,234) analyzed the amount and type of dairy product intake and incident T2D and demonstrated an increased risk for T2D by milk consumption in 5 of 8 countries [8] . The Dutch Lifeline Cohort Study (n = 112,086) investigated the association of non-fermented milk products, milk, and fermented milk products on participants with prediabetes (defined as fasting plasma glucose between 5.6 and 6.9 mmol/l or HbA1c of 5.7-6.4%) and newly diagnosed T2D (defined as fasting plasma glucose > 7.0 mmol/l or HbA1c > 6.5%) [9] . A positive association between fullfat milk consumption (150 g/day) as well as non-fermented dairy products with prediabetes has been shown. Notably, a significant positive association between milk (serving 150 g/day) and predominantly skim milk consumption (150 g/day) with T2D has been observed [9] . Hruby et al.
[10] investigated the type of dairy intake of participants of the Framingham Heart Study Offspring Cohort and found an association of total, low-fat, skim milk, whole milk, and yoghurt intake with incident prediabetes in middle-aged U.S. adults depending on the preexisting glycemic status.
Of all animal protein sources, milk proteins (whey proteins and caseins) provide highest amounts of essential branched-chain amino acids (BCAAs). In comparison to beef proteins, milk proteins provide five times higher amounts of leucine, isoleucine, and valine (g/100 g amino acids), respectively (Table 1) [11] [12] [13] . Cumulative consumption of BCAAs has been associated with increased risk of T2D among participants from three prospective cohorts: Nurses' Health Study (NHS; followed from 1980 to 2012), NHS II (followed from 1991 to 2011), and Health Professionals Follow-up Study (HPFS; followed from 1986 to 2010) [14] . The Hong Kong Dietary Survey correlated increased dairy and meat protein intake with a 39% increased risk of T2D during the transition of a Chinese population from their traditional diet to Western style diet [15] . Fasting serum insulin levels of subsistence dairy-free horticulturalists in the tropical island of Kitava (Trobriand Islands, Papua New Guinea) were 50% lower compared to milk-consuming Swedish controls from the Northern Sweden WHO Monitoring Trends and Determinants in Cardiovascular Diseases (MONICA) cohort [16] . Paleolithic-like diets that exclude milk and dairy products as well as refined sugar have beneficial effects in the prevention and treatment of IR and T2D [17] [18] [19] [20] .
Hyperactivation of mTORC1 in type 2 diabetes
The growth factor and BCAA-sensitive kinase mTORC1 (mechanistic target of rapamycin complex 1) plays a key role in metabolic homeostasis and the regulation of autophagy [21] [22] [23] . Overactivated mTORC1 signaling of peripheral cells of the body (liver, adipose tissue, skeletal muscle) promotes S6K1-mediated IR by negative phosphorylation of insulin receptor substrate 1 (IRS-1) [24] [25] [26] . IR enhances the metabolic demand and burden of β-cells by increasing insulin synthesis and secretion [27] .
Under nutrient-rich conditions, mTORC1 orchestrates cell growth by stimulating biosynthetic pathways, including synthesis of proteins, insulin, lipids, and nucleotides, and by inhibiting cellular catabolism through repression of autophagy pathways [28, 29] . Autophagy is necessary to maintain the structure, mass, and function of pancreatic β-cells. Impaired autophagy by overactivated mTORC1 enhances ER stress associated with an increased risk of β-cell apoptosis [30] . Overactivation of mTORC1 has been linked to the pathogenesis of obesity, IR, and T2D [31] [32] [33] [34] . Recent findings uncover mTORC1's importance as an emerging significant player in the development and progression of β-cell failure in T2D and suggest that mTORC1 may act as a "double-edged sword" in the regulation of β-cell mass and function in response to metabolic stress such as nutrient overload and IR [35] . Hyperactivation of mTORC1 has been observed in pancreatic islets from animal models of T2D and human islets from patients with T2D, which leads to β-cell loss [36] . Elevated mTORC1 activation is a striking pathogenic hallmark of islets in T2D, contributing to impaired β-cell function and survival in the presence of metabolic stress [36, 37] . It has been shown that chronic over-activation of mTORC1 in β-islets from prediabetic patients makes β-cells more prone to trigger apoptosis upon several cellular stressors, allowing the progression from prediabetes to T2D [38] . Intriguingly, Jaafar et al. [39] recently demonstrated in mice that post-weaning β-cell maturation is associated with a switch from mTORC1 activation to activation of 5'-adenosine monophosphate-activated protein kinase (AMPK). The reverse direction from AMPK to mTORC1 activation has been observed in T2D dysfunctional β-cells [39] .
Milk: mammals mTORC1-driver for the postnatal growth period Milk is a specialized nutrient and signaling system of mammals that is physiologically restricted to operate during the lactation period for adequate promotion of mTORC1-dependent postnatal anabolism and growth [40, 41] . Milk consumption activates mTORC1 by enhancing the endogenous synthesis of insulin and insulin-like growth factor-1 (IGF-1) and by transfer of mTORC1-activating amino acids [40, 41] . Milk protein contains abundant quantities of leucine, isoleucine, valine, arginine, glutamine, and methionine as critical stimulators of mTORC1 [42-49] ( Table 1) .
Insulinotropic effect of milk
Milk protein derived BCAAs induce postprandial hyperinsulinemia explaining the high insulinemic index of milk, which is three times higher than its glycemic index [2, 50] . This milk protein-specific effect is mediated by fast intestinal hydrolysis of whey proteins and systemic absorption of released insulinotropic amino acids [51, 52], which stimulate insulin secretion of pancreatic β-cells [53] . About 23% of amino acids of whey protein have insulinotropic effects [54, 55] . Furthermore, whey increases the gastric emptying rate, stimulates the intestinal release of the incretin hormones glucose-dependent insulinotropic peptide (GIP) and glucagon-like polypeptide-1 (GLP-1), and functions as an inhibitor of dipeptidyl peptidase IV [56-59]. Thus, milk-derived BCAAs and incretin signaling enhances insulin synthesis and secretion and thereby increases the metabolic burden of β-cells. Moreover, insulin enhances peripheral activation of AKT-mTORC1signaling increasing the risk of peripheral IR ( Fig. 1 ) [60] . In contrast to milk signaling, recent treatment strategies for T2D are targeted towards reducing the systemic metabolic burden, rather than demanding greater insulin production from an already overstressed β-cell [61] (Fig. 1 ).
Insulin-like growth factor 1
Milk consumption increases the synthesis and plasma levels of IGF-1 [62] [63] [64] . Daily intake of 710 ml of ultraheat-treated milk for 1 month to prepubertal school children, who were not used to ingesting milk, resulted in a significant increase of growth hormone (GH) and IGF-1 pointing to an impact of milk consumption on the somatotropic axis [65] . Tryptophan and methionine, abundant amino acids of the casein fraction of milk (Table 1) , promote hepatic IGF-1 synthesis [65] [66] [67] [68] [69] . Furthermore, cow milk contains bovine IGF-1, which is identical to human IGF-1 [70] [71] [72] . In synergy with insulin, IGF-1 activates the AKT-mTORC1 pathway ( Fig. 1) [41, 43] .
Milk consumption and increased IGF-1 serum levels are associated with increased linear growth and body mass index [73, 74] . Remarkably, untreated individuals with Laron syndrome due to defective GH receptor signaling and congenital IGF-1 deficiency have less IR and lower incidence of T2D than their relatives [75] [76] [77] . In fact, an association of free IGF-1 serum levels and T2D has been reported in the Nurses' Health Study [78] , whereas a nested case-cohort study within the EPIC-Potsdam Study found no association between total IGF-1 serum concentrations with risk of T2D [79] . A longitudinal study in a multiracial cohort supported a correlation between increased IGF-1 and gestational diabetes mellitus [80] . Notably, milk consumption during pregnancy, which is generally recommended by obstetricians and gynecologists [81], may increase maternal IGF-1 levels and infant´s birth weight [82] , a risk factor for obesity and T2D in later life [83] .
mTORC1-activating amino acids
Milk protein is the richest animal source of BCAAs (Table 1) . Caseins are highly enriched in methionine. Whey proteins contain highest amounts of leucine [11, 12] . Milk protein in comparison to beef (4.8 g/100 g) contains higher amounts of glutamine (8.1 g/100 g protein) [13] . Glutamine in synergy with leucine activates mTORC1 [43] . Leucine, methionine, arginine, and glutamine are detected by cellular amino acid sensors that subsequently activate mTORC1 [44] [45] [46] [47] [48] . Leucine is regarded as the primary BCAA activating mTORC1 [41] . Apparently, the composition of milk amino acids has been precisely adapted during mammalian evolution to provide optimized input signals for mTORC1 activation of the milk recipient. In the lysosomal compartment, milk amino acids stimulate mTORC1 in a Rag GTPase-dependent and Rag-GTPaseindependent fashion [84] [85] [86] [87] [88] (Fig. 1) . Amino acid-mediated activation of mTORC1 is further supported by growth factor signals, especially insulin and IGF-1, which, via AKT-mediated phosphorylation of tuberin (TSC2), activate the GPTase Rheb that finally activates mTORC1 [43, 49] . Milk-derived amino acids (leucine, methionine, arginine, glutamine) enhance mechanistic target of rapamycin complex 1 (mTORC1) activity and insulin synthesis and secretion of pancreatic -cells promoting -cell growth during the breastfeeding period. However, chronic milk intake induces endoplasmic reticulum (ER) stress when mTORC1-overstimulation by milk signaling is not physiologically discontinued. Plasma levels of diabetogenic miRNA-29b rise six hours after consumption of pasteurized cow´s milk and might reach the liver and peripheral tissues by exosomal miRNA transfer. miRNA-29b targets dihydrolipoamide branched-chain acyltransferase (DBT), the E2 core component of branched chain -ketoacid dehydrogenase (BCKD), reducing the catabolism of branchedchain amino acids (BCAAs), the metabolic signature of insulin resistance (IR) and T2D. miRNA-148a targets V-MAF musculoaponeurotic fibrosarcoma oncogene family, protein B (MAFB) and DNA methyltransferase 1 (DNMT1) involved in the regulation of -cell differentiation and TOR expression. Milk miRNA-21 via targeting phosphatase and tensin homolog (PTEN) enhances mTORC1 signaling in accordance with milk miRNA-125b-mediated suppression of p53, a key negative regulator of mTORC1 and activator of AMPK. Persistent mTORC1 activation of peripheral cells stimulates S6K1-mediated negative phosphorylation of insulin receptor substrate-1 (IRS-1) promoting IR enhancing -cell ER stress accelerating -cell apoptosis, the metabolic hallmark of T2D. 
Milk fatty acids and MFG-E8
The predominant fatty acid of milk fat globule (MFG) triacylglycerols is palmitic acid. This saturated fatty acid is able to activate mTORC1 in the lysosomal compartment [89, 90] . The MFG membrane protein EGF-factor 8 (MFG-E8), which constitutes over 80% of MFG membrane proteins, likewise activates PI3K/AKT/mTORC1 signaling [91] .
Thus, milk provides multiple macronutrient components that exhibit signaling functions converging in the activation of mTORC1 of the milk recipient.
Milk-derived miRNAs
Fresh and pasteurized cow milk transfers bioactive gene-regulatory micro-ribonucleic acids (miRNAs), which are protected from intestinal degradation by secretion as membrane-coated extracellular vesicles (EVs) and exosomes [92] [93] [94] [95] [96] [97] [98] [99] . It has recently been demonstrated that orally administered cow milk exosomes (50-100 nm) and their specific miRNAs are distributed into various organs of mice, especially the liver [100, 101] . miRNAs bind to their specific target messenger RNAs (mRNAs) leading to attenuation or either complete suppression of gene expression [102, 103] . Cow milk contains more than 400 miRNAs. The predominant bovine miRNA, miRNA-148a, is identical with human miRNA-148a and survives pasteurization and is a major miRNA component of milk fat [104, 105] . miRNA-148a inhibits the expression of DNA methyltransferase 1 (DNMT1) [106, 107] , which is involved in epigenetic regulation of the human genome [108] [109] [110] . Notably, further signature miRNAs of cow milk, miRNA-21 and miRNA-29b, indirectly target DNMT1 [106, 111] . Demethylation of the P2 promoter region of the IGF1 gene increases IGF-1 expression [112] . In addition, the promotor regions of the insulin (INS) and mTOR (MTOR) genes are activated by demethylation [113, 114] . miRNA-21 targets multiple tumor suppressor genes such as phosphatase and tensin homolog (PTEN) resulting in increased PI3K-AKT-mTORC1 signaling [40, 115, 116] . miRNA-125b, miRNA-30d, and miRNA-25 are further miRNA components of cow milk that target p53, the guardian of the genome [108, [117] [118] [119] , functioning as a key inhibitor of mTORC1 [120, 121] . Two p53 target genes, sestrin 1 and sestrin 2, activate AMPK, which phosphorylates and stimulates GAP activity of tuberin (TSC2), thereby inhibiting mTORC1 [122] . Thus, there is substantial evidence that milk-derived miRNAs augment mTORC1 signaling as important driver of postnatal β-cell growth during the neonatal period [123, 124] .
The transcription factor MAFB increases the expression of MAFA, which is important to maintain pancreatic β-cell function in adults [125, 126] . Notably, MAFB is a direct target of miRNA-148a [127] . miRNA-148a has been detected as a major miRNA component of bovine milk and milk fat as well as human MFGs [105, 128] . Notably, MAFA was lower in islets of mice provided milk fat [39] . Thus, persistent milk consumption in adults may maintain an immature βcell phenotype with less MAFA expression and increased mTORC1 activation.
Milk miRNA-29b and impaired BCAA catabolism
Recent studies implicate a strong association between elevated plasma BCAAs and IR [32, [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] . Moreover, Zhou et al. [139] identified a unique genetic link between obesity-associated IR and BCAA catabolic gene expression at the pathway level in human and mouse populations. In genetically obese (ob/ob) mice, rate-limiting branched-chain α-keto acid (BCKA) dehydrogenase deficiency associated with BCAA and BCKA accumulation accompanied the systemic suppression of BCAA catabolic genes. Restoring BCAA catabolic flux with a pharmacological inhibitor of BCKA dehydrogenase kinase (BCKDK, a suppressor of BCKA dehydrogenase) reduced the abundance of BCAA and BCKA and markedly attenuated IR in ob/ob mice. Similar outcomes were achieved by reducing protein (and thus BCAA) intake, whereas increasing BCAA intake did the opposite. This corroborates the pathogenic roles of BCAAs and BCKAs in IR in ob/ob mice [139] . Like BCAAs, BCKAs also suppress insulin signaling via activation of mTORC1. In ob/ob mice and other rodent models of IR and T2D such as streptozotocin-injected mice, Zucker fatty rats, and UC Davis T2D rats, liver-specific insulin receptor knockout, hepatic miRNA-29b, is overexpressed [140, 141] . The miRNA-29 family is among the most abundantly expressed miRNAs in the pancreas and liver. Overexpression of miRNA-29b has also been observed in the muscle, adipose tissue, and liver of diabetic Goto-Kakizaki rats [142] . Levels of miRNA-29a/b/c increased in islets of NOD mice during the phases preceding the manifestation of diabetes and in isolated mouse and human islets exposed to proinflammatory cytokines [143] . miRNA-29a and miRNA-29b contribute to pancreatic β-cell-specific silencing of monocarboxylate transporter 1 (MCT1) and may thus affect insulin release [144] . The miRNA-29 family dictates the balance between homeostatic and pathological glucose handling in diabetes and obesity [145] . Baran-Gale et al. [146] identified 10 β-cell miRNA families as candidate regulatory hubs in a T2D gene network. The most significant candidate hub was miRNA-29, which regulates mRNA levels of several genes critically involved in β-cell functions and development of T2D. Remarkably, acute suppression of the miRNA-29 family in adult mice improved glycemic control [140] .
More than 50% of bovine milk miRNA-29b was still detectable after pasteurization and homogenization of whole and 2% fat milk in comparison to raw milk, whereas one third of miRNA-29b was recovered in skim milk after these procedures [147] . Remarkably, consumption of commercial milk increased miRNA-29b plasma levels of healthy volunteers in a dosedependent manner [148] . Milk miRNA-29b also increased in peripheral blood monocytes after milk intake [148] . It is thus conceivable that milk exosome uptake is responsible for this effect [100, 101, 110] . Part of bovine milk exosome uptake is mediated by bovine immunoglobulin G (IgG), which binds to human neonatal Fc receptor (FcRn) [149] and is highly expressed in adult human liver and other human organs [150] . The mature sequences of human and bovine miRNA-29b are identical (mirbase.org). Notably, Mersey et al. [151] demonstrated that miRNA-29b plays an important role in determining the total amount of BCKD present in the cell. miRNA-29b targets the mRNA for the dihydrolipoamide branched-chain acyltransferase (DBT) component of BCKD and prevents translation when bound. BCKD is composed of a core of 24 DBT (E2) subunits, which are critical for BCKD function [152] . Thus, milk miRNA-29b-mediated suppression of BCKD activity might impair BCAA catabolism [110, 153, 154] , a key metabolic signature of IR and T2D [32, [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] . Milk miRNA-29b-mediated suppression of BCAA catabolism appears to be a protective mechanism preventing BCAA oxidation in order to provide sufficient quantities of BCAAs for postnatal synthesis of BCAA-dependent structural and functional proteins as well as BCAA-mTORC1-driven β-cell proliferation [153] . Physiologically, milk-mediated suppression of BCAA catabolism is terminated after the breastfeeding period in all mammals except Neolithic humans, who after widespread distribution of refrigeration technology in the 1950s, enhanced their intake of pasteurized milk and BCAA-rich milk products [32] . Before the era of the refrigerator, Neolithic humans predominantly consumed fermented milk and fermented dairy products such as yoghurt, in which exosome integrity and miRNA content is reduced due to bacterial fermentation [155] . Pasteurized milk in contrast to fermented milk provides both BCAAs and bioactive miRNA-29b, which inhibits BCAA catabolism. Thus, pasteurized milk has the strongest diabetogenic effect by raising BCAA levels by transfer of BCAAs combined with an inhibitory activity on BCAA catabolism.
DISCUSSION
Milk is mammal´s most sophisticated functional food to ensure abundant BCAA and exosomal miRNA transfer for adequate mTORC1 signaling required for β-cell growth and postnatal tissue maturation. In all mammalian species, except Neolithic humans, this signaling system is confined to the nursing period which substantially affects β-cell function and homeostasis. Recent evidence supports the view that mTORC1-dependent β-cell growth during the lactation period has to switch to AMPK-regulated β-cell function after weaning, when glucose signals are the primary stimulus of the β-cell for insulin secretion [39] . Continued exposure to milk and their miRNAs including IR-promoting miRNA-29b enhance BCAA and miRNA-driven overactivation of β-cell mTORC1. Persistently increased mTORC1 activation of β-cells reduces their capacity for autophagy enhancing chronic ER stress promoting early β-cell apoptosis, the major pathogenic event in T2D [30, 32, 156] . In fact, upregulation of amino acid transport in β-cells during ER stress with increased transfer of leucine and tryptophan involves responses leading to increased protein synthesis, which can be protective during acute stress but leads to apoptosis during chronic ER stress [156] . To improve β-cell metabolic health and to reduce somatic IR, the excessive and continued intake of BCAAs of animal proteins supplied by persistent consumption of milk, dairy products and meat needs to be reduced [137, [157] [158] [159] [160] . Pasteurized milk, widely distributed by refrigeration technology since the 1950s, transfers diabetogenic miRNA-29b into the human food chain [40, 41, 153] . Milk consumption, especially in synergy with excessive glucose intake [3] , is a typical and frequent in a Western diet and may accelerate the pathogenesis of T2D, which is in accordance with epidemiological evidence [6-10].
Based on epidemiological and translational evidence, we conclude that a restriction of BCAArich dairy proteins in conjunction with the elimination of milk-derived miRNAs may be a meaningful dietary intervention to reduce the burden of T2D [32, 110, 153, 161] . Notably, the mTORC1 activator milk exerts the opposite functions of the most commonly used anti-diabetic drug metformin [162] , which activates AMPK, suppresses mTORC1, reduces plasma BCAA levels, and targets BCAAs to the adipose tissue [163, 164] . Future studies should pay attention to the miRNA-29b content of milk and milk products and its impact on the regulation of BCAA plasma levels in relation to T2D prevalence. 
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